Wave Life Sciences Ltd
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -41.0% | -56.8% | +57.1% | -139.0% | – | -89.0% | -5.2% | -12.5% | +126.7% | +121.8% | -94.1% | – | |
| – | -93.1% | -0.2% | -0.2% | -0.6% | +2,946.0% | -96.7% | +1.5% | – | – | – | – | – | |
| – | +52.9% | -53.3% | +57.1% | -139.0% | – | -91.6% | -7.2% | +17.0% | +96.9% | +155.3% | -94.1% | – | |
| – | +7.7% | -1.8% | +20.8% | +2.0% | +8.4% | -9.0% | +7.0% | +5.5% | +15.1% | -10.2% | +8.1% | – | |
| – | +4.1% | -0.8% | +5.5% | +5.2% | +7.3% | +13.8% | -2.0% | +0.5% | +15.5% | +5.8% | +12.1% | – | |
| – | +247.0% | +3.2% | +16.4% | +2.8% | +8.1% | -6.5% | +4.3% | +7.9% | +11.7% | -2.7% | +9.4% | – | |
| – | -520.4% | – | – | – | – | -316.9% | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -305.0% | – | – | – | – | -260.3% | – | – | – | – | – | – | |
| – | +1,000.9% | -100.0% | – | – | – | – | – | – | – | – | – | – | |
| – | -324.2% | – | – | – | – | -260.3% | – | – | – | – | – | – | |
| – | -254.2% | – | – | – | – | -242.4% | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.